[{"id":"1cdd60d2-369d-4e42-890d-606bbb974c28","acronym":"","url":"https://clinicaltrials.gov/study/NCT06010342","created_at":"2023-08-24T16:11:42.524Z","updated_at":"2024-07-02T16:35:10.443Z","phase":"Phase 2","brief_title":"A Study to Evaluate the Efficacy and Safety of TL118 in Solid Tumors Patients","source_id_and_acronym":"NCT06010342","lead_sponsor":"Teligene US","biomarkers":" NTRK1 • NTRK3 • NTRK2","pipe":" | ","alterations":" NTRK1 fusion • NTRK3 fusion • NTRK2 fusion","tags":["NTRK1 • NTRK3 • NTRK2"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e NTRK1 fusion • NTRK3 fusion • NTRK2 fusion"," \u003cb class=\"violet\"\u003e|\u003c/b\u003e TL118"],"overall_status":"Not yet recruiting","enrollment":" Enrollment 60","initiation":"Initiation: 05/01/2024","start_date":" 05/01/2024","primary_txt":" Primary completion: 12/01/2025","primary_completion_date":" 12/01/2025","study_txt":" Completion: 12/01/2025","study_completion_date":" 12/01/2025","last_update_posted":"2024-04-10"}]